Clinical Trial Update: Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 2 study evaluating the combination of gemcitabine and paclitaxel for metastatic breast cancer. The Eli L…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Taxol (paclitaxel)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2009-07-20